Canada Markets closed

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
53.87+1.93 (+3.72%)
At close: 04:00PM EST
52.72 -0.97 (-1.81%)
After hours: 04:01PM EST
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 380.00
52 Week Low 350.94
50-Day Moving Average 359.18
200-Day Moving Average 369.02

Share Statistics

Avg Vol (3 month) 314.07k
Avg Vol (10 day) 320.23k
Shares Outstanding 537.93M
Implied Shares Outstanding 6N/A
Float 88.25M
% Held by Insiders 177.78%
% Held by Institutions 113.46%
Shares Short (May 27, 2021) 4154.99k
Short Ratio (May 27, 2021) 47.86
Short % of Float (May 27, 2021) 41.77%
Short % of Shares Outstanding (May 27, 2021) 40.41%
Shares Short (prior month Apr. 29, 2021) 4120.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec. 27, 2018
Ex-Dividend Date 4Dec. 09, 2018
Last Split Factor 22:1
Last Split Date 3Jul. 26, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar. 30, 2021
Most Recent Quarter (mrq)Mar. 30, 2021


Profit Margin -70.43%
Operating Margin (ttm)26.44%

Management Effectiveness

Return on Assets (ttm)3.82%
Return on Equity (ttm)-21.06%

Income Statement

Revenue (ttm)548.97M
Revenue Per Share (ttm)14.37
Quarterly Revenue Growth (yoy)-15.20%
Gross Profit (ttm)296.66M
EBITDA 168.83M
Net Income Avi to Common (ttm)-386.65M
Diluted EPS (ttm)-10.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.02B
Total Cash Per Share (mrq)27.12
Total Debt (mrq)3.02M
Total Debt/Equity (mrq)0.18
Current Ratio (mrq)2.17
Book Value Per Share (mrq)44.92

Cash Flow Statement

Operating Cash Flow (ttm)45.77M
Levered Free Cash Flow (ttm)526.47M